BC
VCYT icon

Brookfield Corp’s Veracyte VCYT Stock Holding History

Brookfield Corp’s Portfolio VCYT Stock Details VCYT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-38,297
Closed -$1.78M – 736
2021
Q3 		$1.78M Buy
38,297
+16,496
+76% +$720K 0.01% 366
2021
Q2 		$872K Buy
+21,801
New +$932K ﹤0.01% 484

Other funds holding VCYT

AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Brookfield Corp's VCYT Position: Q4 2021 in Review

Brookfield Corp sold out of Veracyte (VCYT) in Q4 2021, closing a stake of 38,297 shares — an estimated $1.78M sold.

Brookfield Corp first reported a position in VCYT in Q2 2021 and held it in 2 quarters. The position peaked at $1.78M in Q3 2021. 217 funds tracked by Wall St. Rank hold VCYT as of Q4 2021.

  • Brookfield Corp reported no remaining Veracyte position as of Q4 2021 after selling out during the quarter.
  • Brookfield Corp sold 38,297 Veracyte shares in Q4 2021, an estimated $1.78M.
  • Brookfield Corp first reported a position in Veracyte in Q2 2021 and held it in 2 quarters.
  • Brookfield Corp's Veracyte position peaked at $1.78M in Q3 2021.
  • 217 funds tracked by Wall St. Rank held Veracyte as of Q4 2021.

Based on Brookfield Corp's 13F filing for Q4 2021, filed 14 Feb 2022.